W. Shih

发表

Group sequential designs using a family of type I error probability spending functions.

J. S. D. Cani, I. K. Hwang, W. Shih, 1990, Statistics in medicine.

Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance

A. Gould, W. Shih, 1992 .

Sample size re‐estimation – journey for a decade

W. Shih, 2001, Statistics in medicine.

Clinical trials for drug registrations in Asian-Pacific countries: proposal for a new paradigm from a statistical perspective.

W. Shih, W J Shih, 2001, Controlled clinical trials.

Blinded sample size re-estimation with unequal variances and center effects in clinical trials

J. Long, W. Shih, 1998 .

Controlling type I error rate for fast track drug development programmes

L. Bijnens, H. Quan, W. Shih, 2003, Statistics in medicine.

Current Controlled Trials in Cardiovascular Medicine

W. Shih, Weichung Joseph Shih, 2002 .

A multi-centre, double-blind randomized study to assess the efficacy and tolerance of sulindac versus placebo in the symptomatic treatment of patients with upper respiratory tract infection.

W. Shih, D. Ebel, A. R. Rhymer, 1985, Current medical research and opinion.

A two-stage sequential design and analysis for comparing binomial rates with possibly random dropouts

H. Quan, T. Capizzi, W. Shih, 1994 .

Sample size and power determination for clustered repeated measurements

Aiyi Liu, E. Gehan, Aiyi Liu, 2002, Statistics in medicine.

Effect of cholesterol-lowering therapy on coronary endothelial vasomotor function in patients with coronary artery disease.

A. Yeung, M. Winniford, M. Kern, 2000, Circulation.

Comparisons between ITT and treatment emergent adverse event analyses

H. Quan, W. Shih, Ji Zhang, 2008, Statistics in medicine.

Approaches to handling data when a phase II trial deviates from the pre‐specified Simon's two‐stage design

Weichung J Shih, Yujun Wu, W. Shih, 2008, Statistics in medicine.

Two‐stage adaptive strategy for superiority and non‐inferiority hypotheses in active controlled clinical trials

Hui Quan, Gang Li, Weichung J Shih, 2004, Statistics in medicine.

Modifying the design of ongoing trials without unblinding.

W J Shih, A L Gould, A. Gould, 1998, Statistics in medicine.

Evaluating correlation with proper bounds

Wei-Min Huang, Wei-Min Huang, W. Shih, 1992 .

Sample Size Reestimation for Triple Blind Clinical Trials

W. Shih, Weichung Joseph Shih, 1993 .

Estimating a survival curve with unlinked entry and failure times

Yujun Wu, Weichung J Shih, Dirk F Moore, 2007, Statistics in medicine.

Testing for treatment differences with dropouts present in clinical trials--a composite approach.

W J Shih, H Quan, H. Quan, 1997, Statistics in medicine.

Analysis of pilot and early phase studies with small sample sizes

Yong Lin, Weichung Joseph Shih, Pamela A Ohman-Strickland, 2004, Statistics in medicine.

Stratified testing for treatment effects with missing data.

H. Quan, W. Shih, 1998, Biometrics.

Current Controlled Trials in Cardiovascular Medicine

W. Shih, 2002 .

Sample Size and Power Calculations for Periodontal and Other Studies with Clustered Samples Using the Method of Generalized Estimating Equations

W. Shih, Weichung Joseph Shih, 1997 .

On study designs and hypotheses for clinical trials with predictive biomarkers.

Yong Lin, W. Shih, 2017, Contemporary clinical trials.

Assessing reproducibility by the within-subject coefficient of variation with random effects models.

H Quan, H. Quan, W. Shih, 1996, Biometrics.

Partial imputation approach to analysis of repeated measurements with dependent drop‐outs

W J Shih, L Wei, Lynn Wei, 2001, Statistics in medicine.

The design and conduct of clinical trials to limit missing data

R. Little, H. Stern, K. Dickersin, 2012, Statistics in medicine.

On the inappropriateness of an EM algorithm based procedure for blinded sample size re‐estimation by T. Friede and M. Kieser, Statistics in Medicine 2002; 21:165‐‐176

A Lawrence Gould, W. Shih, Weichung J Shih, 2005, Statistics in medicine.

Statistical properties of the traditional algorithm-based designs for phase I cancer clinical trials.

W J Shih, W. Shih, Yong Lin, 2001, Biostatistics.

Current Controlled Trials in Cardiovascular Medicine

W. Shih, 2002 .

Elicitation of a Beta Prior for Bayesian Inference in Clinical Trials

Weichung J Shih, Dirk F Moore, Yujun Wu, 2008, Biometrical journal. Biometrische Zeitschrift.

On informative and random dropouts in longitudinal studies.

W J Shih, W. Shih, 1992, Biometrics.

Approaches to handling data when a phase II trial deviates from the pre‐specified Simon's two‐stage design

W. Shih, Yujun Wu, 2008, Statistics in medicine.